Veeva Announces CRO Partnership Program and First Member
Veeva Systems announced that CRO Advanced Clinical both selected its Vault eTMF, and became the first member of its new partnership program.
Veeva Systems announced that CRO Advanced Clinical both selected its Vault eTMF, and became the first member of its new partnership program. According to Julie Ross, Executive Vice President of Advanced Clinical, “A cloud-based eTMF gives us and our clients a strategic advantage. We can speed document collection from start-up through trial close, and our clients get the visibility they need throughout the entire study.” Through the Veeva CRO Partnership Program, Advanced Clinical received expert training and implementation support, and is prepared to deploy Vault eTMF for new and existing studies. Going forward, Advanced Clinical will receive regular checks and training on system updates. Also, as a CRO partner, they benefit from ongoing strategy sessions and Veeva’s marketing outreach.
Veeva Systems announced the new CRO partnership program to support growing trends in eTMF outsourcing and cloud adoption. In a recent Applied Clinical Trials article, http://bit.ly/I1prg6, the author observed that technology vendors are working closely with CROs in developing partner programs that benefit both the CRO as well as the sponsor. "Vendors have implemented strictly controlled, high quality training and testing programs along with user testing (certification), company accreditation and associated branding to recognize high quality CRO partners who are familiar with their technology.”
The full release can be read here.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
